Summary. The effect of deteriorating glycaemic control on the lipoprotein responses to the ingestion of a high fat meal was investigated in seven normolipidaemic Type i (insulindependent) diabetic patients and the results were compared with corresponding responses in seven normolipidaemic control subjects. In addition, the importance of insulin in regulating the postprandial lipoprotein responses was examined by comparing the results obtained from the diabetic patients maintained on a basal infusion of insulin throughout the study with those obtained when a step-up, step-down insulin infusion was administered following the meal. Vitamin A was added to the test meal in all subjects to trace the metabolism of the chylomicron (Sf> 1000) and non-chylomicron (Sf < 1000) fractions in the postprandial period. No differences in fasting and postprandial triglyceride levels nor in the concentration of the chylomicron and non-chylomicron fractions were observed between diabetic and control subjects. In the diabetic patients short-term (two-week) deterioration in glycaemic control did not have any adverse influence on the basal and postprandial lipid responses. However, while the amount of insulin administered after the meal in the diabetic patients did not have any effect on the postprandial triglyceride or chylomicron responses, the concentration of non-esterified fatty acids was significantly higher (p < 0.0005) when only a basal infusion of insulin was administered. In conclusion: 1) Short-term deterioration in glycaemic control does not adversely affect lipoprotein concentrations in Type 1 diabetes. 2) Non-esterified fatty acids appear to be a more sensitive index of insulinization postprandially than triglycerides.
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Poor glycaemic control in patients with Type 1 (insulindependent) diabetes mellitus is associated with abnormalities in fasting lipids, most frequently hypertriglyceridaemia [1] [2] [3] [4] . A number of studies have demonstrated improvements in the abnormal lipoprotein profile when patients who are in poor metabolic control are placed on more aggressive regimens of insulin replacement which result in improvements in the plasma glucose concentrations [5] [6] [7] [8] [9] . These effects are related to the fact that insulin plays a key role in the regulation of very low density lipoprotein (VLDL) production by the liver [10] and is also an important regulator of lipoprotein lipase [11] , the ratelimiting enzyme in the catabolism of both VLDL and enteric chylomicrons.
Patients with Type 1 diabetes frequently experience short-term variations in metabolic control with elevations in the plasma glucose concentration, particularly in the postprandial state. The effect of these alterations in glucose control on the lipid and lipoprotein profiles both in the fasting state and postprandially is not known. In the present study, we have prospectively reduced the insulin dose over a two-week period in Type 1 diabetic patients previously in good metabolic control and measured the effect on plasma lipids. The effect of variations in the acute replacement dose of insulin at the time of the meal ingestion was also studied. The rationale behind this study design was to simulate the short-term variations in glucose control which frequently occur in the everyday lives of patients with Type i diabetes.
Subjects and methods
Studies were performed on seven patients with Type 1 diabetes who were free of complications and otherwise in good health and seven non-diabetic control subjects well matched for age (30.3 _+ 2.0 years vs 30.0 + 2.2 years, mean +_ SEM: range 21-40 years), sex (6 females and 1 male in each group) and BMI (23.9 + 0.8 kg/m 2 vs 23.8 _+ 0.9 kg/m2: range 20.5 to 27.1 kg/m2). All subjects were normolipidaemic as defined by fasting plasma triglycerides < 150 mg/dl, total cholesterol < 90th percentile and HDL cholesterol > 5th per-centile for the U.S. population for age and sex (12) . Other than insulin, no subject was taking any medication known to affect lipid metabolism (i.e., oral contraceptives, thiazide diuretics, Beta blockers, lipid-lowering agents) and all had stable body weight for at least one month prior to the study. The duration of diabetes in the seven diabetic patients was 16.3 _+ 0.8 years (range 13 to 19 years) and HbA~c concentration 9.9+_0.4% (range 8.8 to 11.7%), the mean HbA~c for the non-diabetic population in this laboratory being 5.16 + 0.06%. Six of the diabetic subjects were treated with a conventional insulin regimen consisting of NPH and regular human insulin and the remaining patient was treated with the continuous subcutaneous insulin infusion (CSII) pump. Individualized weightmaintaining diabetic diet patterns were designed for each control subject and dietary patterns were followed for two weeks prior to receiving the high fat test meal. Subjects gave written informed consent and the protocol was approved by the Institutional Review Board.
Study design
Type i diabetic patients were studied on three occasions each, two weeks apart and control subjects were studied on a single occasion only. On each occasion subjects received the identical lipid-rich test meal. The study was designed to examine:
1. The effect of variations in plasma glucose control during the preceding two-week period on fasting and postprandial lipid and lipoprotein responses.
2. The effect of variations in the dose of insulin administered immediately following the meal on the metabolism of triglyceride-rich particles in the postprandial period.
3. The differences in postprandial lipoprotein metabolism between Type i diabetic patients in moderate glycaemic control and nondiabetic matched control subjects.
To address these issues, the three studies involving Type i diabetic patients were designed as follows:
1. Poor control/basal infusion: For this study, the daily insulin dose for the two weeks preceding the test meal was decreased by approximately one third, in order to raise the mean pre-meal glucose to the 14-17 mmol/1 range. Subjects monitored urine for ketones daily and none developed ketonuria. After two weeks, following a 14 h overnight fast, subjects were admitted to the Clinical Research Centre (CRC) having administered their last subcutaneous insulin close 14 h previously or, in the case of the patient being treated with CSII, the normal nocturnal basal insulin infusion was continued overnight (rate 1.3 U/h). The mean insulin dose administered on the evening prior to the study to the six patients receiving conventional insulin therapy was 18 + 2 U. Following admission, an intravenous catheter was placed in each forearm, one for blood sampling and one for insulin infusion. The arm containing the sampling catheter was maintained in a heating blanket to ensure arterialization of the venous sample and physiological NaC1 (0.15 mol/1) was infused through this catheter to maintain patency. Thirty minutes prior to the test meal, a low basal infusion of insulin (Eli Lilly Co., Indianapolis, Ind., USA) was started in the other arm at 0.4 UPa and continued throughout the 24 h study period.
2. Good control/basal infusion: In this study, subjects were placed in good metabolic control during the preceding two weeks but the insulin dose was maintained at basal levels following ingestion of the test meal. Subjects were admitted to the CRC on the evening prior to being studied. An intravenous infusion of regular human insulin was started in a forearm vein and blood glucose was held constant in the 5-6 mmol/1 range according to the method described by White et al. [13] . Using this approach, the mean insulin infusion rate required to maintain euglycaemia overnight was 1.1 + 0.2 U/h. After fasting overnight for 14 h, a second intravenous sampling catheter was inserted into the opposite forearm. Thirty minutes prior to meal ingestion, the insulin infusion rate was changed to 0.4 U/h and maintained constant at this rate for the duration of the 24 h study.
3. Good control/step-up infusion: This was identical to the good control/basal infusion study with the exception that at the start of the test meal, the insulin infusion was increased incrementally so that the peak postprandial glucose level did not rise above 10.0 mmol/l. The rate was then slowly decreased and after 6 to 8 h, the glucose level was held constant at 5-6 mmol/1 by a variable rate insulin infusion. During the 24 h following the meal the mean insulin dose administered to the diabetic patients was 36. 9 _+ 2.8 U with 45.4 + 3.8% of the total dose being administered in the first 4 h as the insulin dose was being incrementally increased in an attempt to simulate the normal insulin and glucose responses observed in the peripheral circulation in the postprandial period. This approach will not however reproduce the high portal venous insulin concentrations normally attained in the postprandial period in non-diabetic subjects, levels which are not seen in the peripheral circulation due to the large hepatic extraction of insulin.
The order of the three diabetic studies was randomized using a table of random numbers. Glycaemic control during each preceding twoweek period was monitored by subjects at home using a portable reflectance meter.
The non-diabetic control subjects were admitted to the CRC on the morning of the test meal following a 14 h overnight fast. They did not receive an insulin infusion and a single sampling intravenous catheter was placed in a forearm vein. The test meal and sampling was identical to that described for the diabetic subjects (see below).
The detailed composition of the test meal which contained 60 g fat/m 2 body surface area has been previously described (14) . To trace the metabolism of chylomicrons and chylomicron remnants in the postprandial period, Vitamin A (Aquasol A; 5,000 U/0.1 ml; Armour Pharmaceutical Co., Kankakee, Ill., USA) was added to halfa cup of milk and ingested at the start of the meal. Each subject received 60,000 U Vitamin A/m 2 body surface area. Vitamin A when ingested with fat is absorbed predominantly as retinyl palmitate (RP), packaged within the chylomicron core. RP is not exchanged with core lipids of higher density lipoprotein particles to any significant extent in the early postprandial period and remains an integral part of the chylomicron remnant particle after hydrolysis of chylomicrons by lipoprotein lipase, finally being taken up with the remnants by the liver where it is not resecreted with VLDL [15] [16] [17] [18] [19] . The measurement of RP levels in serum postprandially therefore can be used to study in isolation, the metabolism of exogenous (dietary) triglyceride-rich particles, an approach which is not possible through the measurement of serum triglyceride levels alone. In these studies we measured RP levels in whole serum and in serum which had been ffactionated into large chylomicron (Svedberg flotation units (Sf) > 1000) and small non-chylomicron (Sf < 1000) fractions as previously described [15, 20] , the non-chylomicron fraction consisting mainly of RP-labelled chylomicron remnants.
Having consumed the test meal, all subjects did not eat again for 24 h but were allowed free access to water after 8 h. Blood samples for glucose, insulin, C-peptide and lipid parameters were drawn before the meal and every hour after the meal up to 6 h, then every 2 h up to 14 h and at 24 h.
Chemical determinations
The methods used for the separation of the lipoprotein fractions and for analysis of the various lipids in each fraction have previously been described [14] . Non-esterified fatty acids were determined using the colorimetric chemical method described by Mikac-Devic [21] . Protein content of the lipoproteins was quantitated by a modi- Results are expressed as mean + SEM. a p = 0.0001 fled Lowry procedure [22] with sodium dodecyl sulphate to disrupt the lipid micelles, Plasma for retinyl ester determination, having been collected in aluminium foil-covered tubes to minimize light exposure was separated immediately by centrifugation (3,000 rev/min) for 10 min at 4 ~ and then subjected to preparative ultracentrifugation for 21 rain at 25,000 rev/min in a Beckman SW55TI rotor to float chylomicron particles of Sf> 1,000. Aliquots of whole plasma, Sf > 1,000 fraction and Sf < 1,000 fraction were stored at -70 ~ and assayed later for retinyl ester using a modification [14] of the method of De Ruyter and De Leenheer [23] .
Glucose measurement and radioimmunoassays of insulin and C-peptide. Serum insulin [24] and plasma C-peptide [25] were measured as previously described. Since two of the diabetic patients had detectable levels of insulin antibodies in their serum, insulin concentrations were only measured in five of the seven diabetic patients studied. Plasma glucose was measured by glucose analyser (YSI model 23A, Yellow Springs, Ohio, USA).
Statistical analysis
All results are expressed as the mean + SEM. The absolute and incremental areas under the respective response curves were calculated as summary measures by the trapezoidal rule. To test for differences in response to the three protocols in Type 1 diabetes, a repeated measures ANOVA was performed with a Tukey allowance for multiple comparisons (p < 0.05 was regarded as statistically significant). To test for differences between the non-diabetic control and diabetic subjects, the responses under the good control/step-up infusion protocol were compared to those in control subjects by the two sample t-test. (This was the primary comparison of interest because the insulin increment in the diabetic subjects mimicked the non-diabetic response as closely as possible;p < 0.05 was regarded as statistically significant). We also compared the two other diabetic protocols with the normal control subjects and here a p-value of < 0.025 was regarded as statistically significant to allow for multiple testing. For relevant comparisons the 95% confidence intervals are also reported. Throughout the manuscript, the p-value for testing the overall hypothesis of equal means is reported while the significance of differences in the post hoc tests were conducted at the 5% level. Pearson correlation coefficients between all measured variables and areas under the postprandial concentration curves were calculated. Data analysis was performed using the Statistical Analysis System (SAS Version 6 for Personal Computers, SAS Institute, Cary, NC, USA).
Results

Preprandial lipid and glucose levels (Table 1)
The mean pre-meal blood glucose levels and daily insulin dose for diabetic subjects for the two weeks prior to each test meal in addition to the fasting lipid levels on the morning of each study are listed in Table 1 . On average, in the poor control/basal infusion study, the daily insulin dose was decreased by approximately one third and this resulted in an increase in the mean daily plasma glucose level from approximately 7.5 mmol/1 to 13 mmol/1. Mean pre-meal blood glucose measurements during the twoweek period were significantly greater in the poor vs the good control period Co = 0.0001). However, despite the increase in the plasma glucose, fasting lipid parameters did not differ significantly between any of the three protocols in the diabetic patients or between diabetic and control subjects. The 95% confidence interval for differences between the fasting triglycerides of the poor control/basal infusion protocol and the good control/basal infusion protocol was -0.20 to 0.12 mmol/1 and between the poor control/basal infusion protocol and the good control/stepup infusion protocol was -0.23 to 0.09 mmol/1. (Fig. 1) Following the overnight euglycaemic insulin infusion, the fasting glucose for the good control/basal infusion protocol was similar to the good control/step-up infusion protocol (5.4 + 0.2 mmol/1 vs 5.7 + 0.2 mmol/1) and only the latter was slightly higher than the fasting glucose concentration in the control subjects (5.0 + 0.2 mmol/1, p < 0.05). When maintained in poor glycaemic control for two weeks, the diabetic patients had significantly higher blood glucose concentrations on the morning of the test meal (15.5 + 1.2 mmol/1,p = 0.0001).
Postprandial glucose and insulin concentrations
Following ingestion of the test meal in the good control/basal infusion study, the glucose rose to a maximum of 20.2+0.6mmol/1 at 5h and decreased slowly to (78.0 + 6.8 pmol/1 vs 37.7 + 5.2 pmol/1, p < 0.001). In the good control/basal infusion and poor control/basal infusion studies, insulin concentrations did not change significantly during the 24 h postprandial period, the mean insulin level being 44.7 + 1.8 pmol/1 and 49.0 + 2.3 pmol/1, respectively. In the good control/step-up infusion protocol, the peak insulin was 360.0 + 69.6 pmol/l at 3 h, a 3.9-fold increase over baseline. Peak insulin level in control subjects was 166.2 + 43.1 pmol/1 at i h, a 4.4-fold increase over baseline. C-peptide remained suppressed in all diabetic patients after the meal, confirming an absolute deficiency of endogenous insulin production in these patients. The mean C-peptide concentration in the control subjects before the meal was 0.34+0.06 nmol/1. The C-peptide levels increased following the meal, reaching a maximum of 1.13 + 0.21 nmol/l at 2 h.
Postprandial triglycerides, H D L-cholesterol and total cholesterol levels
Plasma triglyceride concentrations rose to a maximum at 3 to 5 h following the test meal in all groups (Fig. 2 ). There were no differences in triglyceride increment, peak triglyceride response or timing of peak response between the three insulin protocols in the diabetic patients or between diabetic and control subjects.
HDL-cholesterol (Fig. 2) decreased significantly from baseline in all three diabetic protocols and also in the control subjects at 3 to 5 h (p < 0.0005). HDL-cholesterol then rose initially towards baseline in all protocols and there was a later overall lowering of HDL-cholesterol in the three diabetic protocols but not in the control subjects. However, none of these changes in HDL cholesterol concentrations after the first 5 h were statistically significant. HDL-cholesterol tended to be highest at all times in the diabetic poor control/basal infusion study but this was of borderline significance (p < 0.05).
Total cholesterol tended to decrease overall with time after the meal but there was extreme individual variability within each group and overall no clearly significant trends were detected.
12.6 + 0.8 mmol/1 at 14 h. When the insulin infusion rate was incrementally increased after the meal, the glucose concentration rose to a peak of 8.8 _+ 0.6 mmol/1 at i h and then stabilized between 5 and 6 mmol/1 from 6 h onwards.
In the poor control/basal infusion study the postprandial increase in glucose was greater, reaching a maximum of 23.0 + 0.5 mmol/l at 4 h and then slowly declining to 12.5 + 0.6 mmol/1 at 14 h. Control subjects demonstrated very little postprandial increment in glucose concentration as demonstrated in Figure 1 .
Insulin levels at the start of the meal were similar for all three protocols in the diabetic patients but these levels were significantly higher than those in the control subjects only in the good control/step-up infusion protocol Postprandial non-esterified fatty acids (NEFA ) (Fig. 2) In both the good control/basal infusion and the poor control/basal infusion protocols, the NEFA concentrations rose within i h following the test meal with a peak at about 3 h. The areas under the respective curves for these two studies were 23.74 _+ 1.35 mmol. 1-j-24 h-1 and 24.23 + 1.31 mmol. 1 -1.24 h-~ and were greater than for the good control/step-up infusion protocol (16.03_+ 1.58 mmol-1 1.24 h -1, p < 0.0005) and the control subjects (18.51 + 0.87 mmol. 1-1.24 h-1, p < 0.01). In the latter two studies, there was an early decrease in NEFA before returning towards baseline levels. In the good control/step-up infusion protocol, NEFA decreased from 0.677 + 0.127 mmol/1 at zero time to 0.433 + 0.057 mmol/1 at 2.9 h (p < 0.05) and tween the three diabetic protocols or between diabetic and control subjects.
Retinyl palmitate (RP) (Fig, 3)
There were no significant differences in RP increment, peak RP response or timing of peak response when measured in whole plasma, chylomicron fraction (Sf> 1000) or non-chylomicron fraction (Sf< 1000) be-
Significant correlations (Table 2)
Fasting triglyceride concentration correlated significantly with the area under the chylomicron RP curve in all three diabetic protocols as well as with the postprandial incremental area under the triglyceride curve in the good Abbreviations: RP = Retinyl palmitate control/step-up infusion and the good control/basal infusion protocols. There were no significant correlations between fasting triglycerides and area under either the whole plasma RP or non-chylomicron RP curves.
Discussion
The present study was designed to examine the effects of short-term alterations in glycaemic control and peri-meal insulin replacement on postprandial lipoprotein metabolism in Type 1 diabetes. While a number of previous studies have examined the effects of improvement in diabetic control on lipoprotein metabolism both in the fasting and postprandial periods [5] [6] [7] [8] [9] , this is to our knowledge the first study of postprandial triglyceride and lipoprotein metabolism in Type 1 diabetes following deliberate attempts to worsen the level of glucose control. We found that two weeks of moderate deterioration in glycaemic control (no ketosis) did not alter either fasting or postprandial lipids and moreover that following an overnight euglycaemic insulin infusion, the level of insulin replacement at the time of the meal did not influence the metabolism of ingested fat. Non-esterified fatty acids (NEFA), on the other hand were significantly affected by acute variations in insulin levels and therefore appear to be a far more sensitive index of insulinization than triglycerides. The negative findings in this study were unexpected in view of the experimental evidence demonstrating that short-term improvement in glycaemic control over a two to three week period in chronically poorly-controlled Type 1 patients results in a decrease in fasting triglycerides. Kinetic studies have demonstrated that such decreases are due to reduced hepatic VLDL triglyceride synthesis rates rather than to increased clearance rates [8, 26] . While deteriorating glycaemic control for periods as short as three weeks might therefore be expected to lead to an increase in VLDL triglyceride synthesis and a subsequent increase in serum triglyceride levels, the latter was not observed in our study. Although the reason for this discrepancy is not immediately apparent, it is conceivable that the rate limiting step responsible for suppressing VLDL synthesis during periods of good control may be different from the rate limiting step regulating enhanced VLDL production as the level of diabetic control deteriorates. During periods of good glycaemic control, the abrupt fall in triglyceride levels which has been reported may be a reflection of a rapid inhibition of lipolysis leading to an immediate reduction in the amount of substrate available for VLDL triglyceride synthesis, whereas during periods of poor control, the hepatic response to the increased availability of substrate may take some time to manifest. Whatever the mechanism, since fasting triglyceride levels in both diabetic and control subjects were similar in this study and since the incremental triglyceride response to a meal in diabetic and in non-diabetic patients is critically dependent on the basal triglyceride concentration [9, 14] , it is not surprising that the postprandial triglyceride and RP responses in both groups were similar.
Although lipoprotein lipase activity has been shown to increase in response to insulin and glucose stimuli [27] [28] [29] , there was no observed difference in postprandial chylomicron clearance following the overnight euglycaemic insulin infusion when insulin was either held constant at a low basal rate or increased after the meal. It thus seems likely that the peripheral hyperinsulinaemia induced by the overnight insulin infusion was sufficient to result in maximum stimulation of lipoprotein lipase activity and further increases in postprandial insulin levels were unable to stimulate lipolytic activity further.
NEFA concentrations rose significantly after the meal when the insulin infusion rate was held constant at 0.4 U/h but did not increase when the insulin infusion was increased four-fold after the meal to simulate the physiological increase in insulin secretion rate which occurs postprandially. Chylomicron triglycerides are hydrolysed to NEFA prior to their entrance into adipose tissue cells [30] and the key factors affecting deposition in the cells are the rate of hydrolysis by lipoprotein lipase and rate of re-esterification of NEFA in the tissue [31] . Since the NEFA rise in patients with low basal insulin levels occurred acutely at the time of the meal, it is most likely that the NEFA's originate from lipolysis of enterically-derived triglycerides packaged within chylomicrons and this rise is inversely related to the degree of effective insulinization at the time of the meal. In support of this latter observation, we have previously demonstrated an early decrease in NEFA levels at 1 to 3 h after the meal in association with a rapid rise in insulin levels in a group of non-diabetic obese subjects [14] . This phenomenon is demonstrated again in the present study, not only in the control subjects but also in the Type 1 diabetic patients when insulin was incrementally increased at the start of the meal.
We conclude that in normotriglyceridaemic Type 1 diabetic patients, short-term deterioration in glucose control resulting from reduction in insulin dose does not alter basal and postprandial lipoprotein concentrations. On the other hand, NEFA disposal in the postprandial state appears to be far more sensitive to effective ambient insulin levels at the time of the meal.
